Navigation Links
EU Move Against Mercury Should Be Adopted in India: NGO

A Delhi-based environmental group Friday welcomed the European Union (EU) Parliament's resolution to ban mercury trade which causes environmental pollution, and urged the Indian government to do likewise.

Toxics Link and other green groups hailed the EU resolution on Wednesday.

The group had called upon governments across the world to ban import of mercury at the 24th United Nations Environment Programme (UNEP) in February.

In one of its studies carried out in a few hospitals in the capital, Toxics Link found high concentration of mercury in the hospital indoor air, revealing the serious threat it posed to staff and patients.

Earlier, a detailed national study, 'Mercury: Poison in Neighbourhood', had shown that a cross section of the society, ranging from students to waste pickers, come in contact with the metal in some way or the other.

Mercury is a neurotoxin, which means that it can affect the nervous system, and can cross blood and placental barriers and cause developmental disorder.

Commenting on the EU resolution, Ravi Agarwal, director Toxics Link, said: "Europe has been the largest exporter of mercury, which figures on the top of the list of deadly contaminants considered a serious hazard to health and environment.

"And since India is the second largest user and importer of the heavy metal, after China, this development is nothing short of a turning point".

In July last year, Minister of State for Environment and Forests Namo Narain Meena had said that though the government was aware of the health hazards that the liquid metal causes, yet there was no proposal to curb its current free import and trade.

Agarwal hoped the Indian government would take a cue from the initiative against the lethal metal and ban its import.


'"/>




Page: 1

Related medicine news :

1. AAI Pharma Files Lawsuit Against Dr. Reddys Laboratories
2. Diabetics Need to Guard Against Nail Fungus
3. New Weapon Against Germs
4. Estrogen Found To Protect the Colon Against Cancer
5. Diet Found To Offer Protection Against Leukemia
6. Olive Oil Found To Offer A Protective Effect Against Breast Cancer
7. WHO Issues Caution Against Bird Flu Epidemic
8. New Supplement Found To Be Effective Against Sunburn
9. Intense Fight Against Polio In India Gets Results
10. Prime Minister Manmohan Against Incentive-Based Population Control
11. Scientists Warn Against Food Borne Illnesses
Post Your Comments:
(Date:5/12/2008)...sles, Nail Fungus and the Dreaded Summer Yeast Inf...hile the pleasures of summer,abound, warm weather ...en,aren,t prepared for., Feel your best with thes...ing some elusive summertime pitfalls., From The T...n! After,just one hour of exposure, hair begins sh...
(Date:5/11/2008)...May 11 /PRNewswire/ -- As the global community obs...ond most deadly cyclone of all,time and the associ...n aid,for cyclone victims, the Alumni Myanmar Inst...oactive-and more importantly, successful-in initia...yanmar where 100,000 people,are assumed dead. AMIM...
(Date:5/11/2008)...thousands of homeless forced to migrate north for ...ar with water, rice, survival ...swire-FirstCall/ -- The lives of,thousands of cycl...le out,of the shattered Irrawaddy Delta to find fo...f 26 shelters across the Myaung Mya region of Myan...
(Date:5/11/2008)... bought over the counter and safely used at home ,...en you,re doing your spring cleaning, don,t forget...asy way for people with spring allergies, nasal co...relief, says Dr. Melissa Pynnonen, co-director of ...or in the University of Michigan,s department of o...
Breaking Medicine News(10 mins):Health News:A Woman's Summertime Guide to Healthy Living From Head-to-Toe 2Health News:A Woman's Summertime Guide to Healthy Living From Head-to-Toe 3Health News:Alumni Myanmar Institutes of Medicine Association (AMIMA) Races Time to Help Cyclone Victims 2Health News:Crisis in Myanmar Relief Camps: Mass Exodus Sets Stage for Public Health Emergency 2Health News:Nasal Irrigation Can Help Fight Spring Allergies 2
...ho have higher dietary intake of foods with omega-...educed risk of advanced age-related macular degen...itamin D may have a reduced risk of the early stag...ports in the May issue of Archives of Ophthalmolog...
...art disease and diabetes are less likely to receiv... than men who have similar health problems , accor...ile previous research has shown that women less fr...are such as angioplasty for heart disease, few stu...
...-like dietary supplement has been found to suppres...e sclerosis and type 1 diabetes mellitus, accordi...nces researchers. In studies on mice, Dr. Michae...UC Irvine Center for Immunology found that N-acety...
...y researchers at UCL (University College London) d...nfluenced by childhood environment . This suggests... years of age that determines the rate at which gi...heir reproductive hormone levels reach as adults. ...
Other Medicine News:Health News:Higher Intake of Fish and Vitamin D Reduces the Risk of Age-related Macular Disease 2Health News:Higher Intake of Fish and Vitamin D Reduces the Risk of Age-related Macular Disease 3Health News:Women With Heart Disease and Diabetes Less Likely to Receive Proper Care: Study 2Health News:Women With Heart Disease and Diabetes Less Likely to Receive Proper Care: Study 3Health News:Glucosamine-like Supplement Inhibits Multiple Sclerosis, Type 1 Diabetes 2Health News:Female Reproductive Function Influenced by Childhood Environment 2Health News:Female Reproductive Function Influenced by Childhood Environment 3
(Date:5/7/2008).../- Shire plc (LSE: SHP,Nas...l company, today,announced findings from a new dat... differences with DAYTRANA(TM) (methylphenidate tr... 12 years with Attention Deficit,Hyperactivity Dis...irmed,that DAYTRANA has an established safety prof...
(Date:5/7/2008).../- Shire plc (LSE: SHP,Nas...l company, presented,today at a major scientific m...ults of INTUNIV, a selective alpha-2A-agonist. Thi...tion, which is being evaluated for the,treatment o...Disorder,(ADHD). The data demonstrated that INTUNI...
(Date:5/7/2008)...., May 7 /- Johnson & Johns...al analysts on Friday, May 9,at 4:00 p.m. (Eastern...s,(APS) annual meeting in Tampa, Fla. Phase 3 clin...dol immediate release (IR), a novel centrally acti... time at APS., A pre-recorded Webcast, with the l...
(Date:5/7/2008)..., May 7 /- New Phase 1,clin... were presented by,Nektar Therapeutics (Nasdaq: N...can Pain Society (APS) in Tampa, Florida. In this ...wn to have substantial oral bioavailability,with r...up to ten times the,known half-life of unPEGylated...
Breaking Medicine Technology:New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 2New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 3New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 5New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 6New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 7Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 2Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 3Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 4Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 5Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose 6NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 2NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 3NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 4NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 5NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting 6Customized treatments for sepsis lower treatment time and reduce length of ICU stays 13098 1Customized treatments for sepsis lower treatment time and reduce length of ICU stays 13098 2Abraham Lincoln Presenter to Speak in Tulsa This Saturday 13094 1Poll Shows Strong Doubts About Effectiveness of Federal Employment Verification System 2352 1Poll Shows Strong Doubts About Effectiveness of Federal Employment Verification System 2352 2AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 1AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 2AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 3AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 4AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 5AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 6AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 7AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 8AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 9AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 10AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31 2007 13093 11
...ional Symposium on,Myelodysplastic Syndromes, TAMP...results,from a pivotal Phase II trial evaluating R... known as myelodysplastic syndromes (MDS),were pre...fitt,Cancer Center & Research Institute, at th...ing place in Florence, Italy.,Breakthrough data pr...
...re-FirstCall/ -- DURECT,Corporation announced toda...reholders with an update on its truncated Phase 3,...g for the,treatment of Alzheimer,s disease. Voyage...erved positive outcome trends among,women, but no ...ently verified the analysis performed or conclusio...
Other Medicine Technology:Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 2Study Continues to Show Patients With Myelodysplastic Syndromes,Treated With Revlimid are Living Longer and Remaining Transfusion,Independent 3DURECT Provides an Update to the Memryte Program Under Development,by Voyager Pharmaceutical Corp 2
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: